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Disjunction of pairs of homologous chromosomes during the first meiotic division (MI) 
requires anaphase-promoting complex (APC)-mediated activation of separase in budding 
yeast1,2 and C.elegans3,4,5 but not X.laevis6,7, and it is not clear which model best fits the 
mammalian system. Here we show that homologue disjunction in mouse oocytes is 
dependent upon proteolysis of the separase inhibitor securin and the Cdk1 regulatory sub-
unit cyclin B1. Proteolysis of both proteins was entirely dependent upon their conserved 
destruction box (D-box) motifs, through which they are targeted to the APC8. These data 
indicate that the mechanisms regulating homologue disjunction in mammalian oocytes 
are similar to those of budding yeast and C.elegans.   
 Completion of maternal MI is marked by formation of the first polar body (PB).  
Oocytes of MF1 mice produce PBs at 8-11 h after entry into MI at germinal vesicle 
breakdown (GVBD). We found that securin is expressed in mouse oocytes during 
progression through MI (GVBD + 4.5 h; Fig.1a). To determine whether it is degraded 
before exit from MI we performed timelapse measurements of GFP-tagged securin, 
which is a valid marker for endogenous securin in mammalian cells9. Timelapse 
fluorescence measurement of oocytes (n=26) injected with mRNA encoding either human 
securin::GFP (n=14) or mouse securin::GFP (n=12) showed that securin::GFP 
accumulated gradually for 7-9 h after GVBD, declined over the next 2-3 h, then increased 
again (Fig. 1b). PB formation occurred at the end of the decline phase. Preliminary 
experiments indicated that excess securin::GFP inhibited PB formation, which is 
consistent with reports on the effect of exogenous cyclin B1 in mouse oocytes10. We 
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therefore deliberately injected low levels of securin::GFP mRNA (~1 pg). Peak 
fluorescence intensities varied from 1-3 fold autofluorescence. These levels of exogenous 
securin did not inhibit PB formation, which was observed in 19/26 securin::GFP-injected 
oocytes compared with 14/18 uninjected control oocytes. The presence of DNA in the PB 
and in the oocyte (Fig. 1c), indicated that homologue disjunction was not inhibited.   
To establish whether proteolysis of securin was required for homologue 
disjunction, we injected oocytes (n=17) with low levels of mRNA (~1 pg) encoding 
either a human (n=11) or mouse (n=6) D-box mutated securin variant (securindm::GFP). 
Timelapse fluorescence measurements showed that both human and mouse 
securindm::GFP were stable for the duration of the experiment (GVBD +14 hr; Fig. 1d).  
This contrasts with findings in mitosis showing that D-box mutated securin is degraded 
via its KEN box motif 9,11, and suggests that the APC activator Cdh1, which targets the 
KEN box8, is either absent or inhibited in MI oocytes.  
In contrast to wild type securin::GFP, PB formation was inhibited in oocytes 
expressing equivalent levels of securindm::GFP. The fluorescence intensities of 
securindm::GFP and securin::GFP at 7:40 h after GVBD, which corresponds to mean time 
of peak expression in securin::GFP-injected oocytes, were 1-2.9 times autofluorescence 
(mean 1.9 ± 0.5) and 1-3 times autofluorescence (mean 2.3 ± 0.18) respectively. 
However, PB formation was observed in only 2/17 securindm::GFP-injected oocytes 
compared with 9/13 uninjected controls (P=0.001). PBs formed by oocytes expressing 
securindm::GFP (n=2) were resorbed within 20 min of extrusion. DNA labeling showed 
that oocytes, including those that produced transient PBs, had a metaphase configuration 
(Fig.1e). Air-dried chromosomes spreads prepared at 16 h post GVBD showed that 
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anaphase onset was inhibited since the bivalents remained intact (n=7/7 oocytes; Fig. 1f). 
Both uninjected control oocytes and oocytes containing equivalent levels of securin::GFP 
had undergone homologue disjunction and extruded PBs at this time point. Tubulin 
immunolabelling of oocytes fixed at 14-16 h after GVBD revealed a bipolar spindle with 
chromatin aligned at the equator (n=6/6; Fig. 1g). Maintenance of the bipolar spindle was 
not due to inhibition of cyclin B1 proteolysis (See Supplementary Information, Fig. S1), 
but was likely due to synthesis of more cyclin B1 and its subsequent stabilization by the 
Mos/---/MAPK (mitogen-activated protein kinase) pathway. In support of this, MAPK 
activity is sustained during MI arrest in mouse oocytes (unpublished data).  
In vertebrate mitosis, non-degradable cyclin B1 inhibits separation of sister 
chromatids in a dose-dependent manner 9,12. To determine whether homologue 
disjunction was also inhibited in the presence of non-degradable cyclin B1 we injected 
mouse oocytes (n=12) with low levels of mRNA encoding ∆90::GFP, a D-box truncated 
variant of cyclin B1::GFP, which has previously been shown to activate Cdk1 in MI 
ascidian oocytes13. In contrast to full length cyclin B1 (See Supplementary Information, 
Fig. S2a), timelapse fluorescence measurements showed that ∆90::GFP was stable in MI 
oocytes (See Supplementary Information, Fig S2b) and PB formation was inhibited. PBs 
were observed in 0/12 ∆90-injected oocytes compared with 9/12 oocytes expressing 
equivalent levels of full length cyclin B1::GFP. DNA staining (n=12 oocytes) revealed 
that homologues maintained a metaphase or metaphase-like configuration (See 
Supplementary Information, Fig. S2c). Immunolabelling of tubulin in fixed oocytes 
showed an intact spindle with chromosomes at the spindle equator. However, misaligned 
chromosomes were occasionally present (2/7 oocytes; See Supplementary Information, 
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Fig. S2d). Air-dried chromosome spreads of ∆90-injected oocytes (n=7) showed intact 
bivalents at 15-16 h after GVBD (See Supplementary Information, Fig. S2e). Control 
uninjected oocytes and oocytes injected with full-length cyclin B1::GFP had produced 
PBs at this time point.  Inhibition of homologue disjunction in the presence of ∆90 was 
independent of securin since securin proteolysis was not inhibited in ∆90-injected 
oocytes (See Supplementary Information, Fig. S2f). 
Since the effect of ∆90 is dose dependent in mitotic systems 9,12, we were 
interested to determine whether very low levels ∆90 would inhibit homologue 
disjunction. GV stage oocytes (n=6) were injected with ∆90 protein to give an estimated 
oocyte concentration of 15-45 nM, which is 13-40 fold less than the estimated 
endogenous level of cyclin B1 in mouse oocytes14. Both PB formation and homologue 
disjunction were inhibited (6/6 oocytes).     
Our findings indicate a dual system of regulation in which proteolysis of both 
securin and cyclin B1 is required for homologue disjunction in mouse oocytes. This is 
consistent with findings in vertebrate mitotis9,12 and suggests regulation by separase. 
These data provide a framework for a mechanistic approach to the problem of 
segregation errors during maternal MI. This is an important issue in human reproductive 
health, since such errors account for 80% of constitutive aneuploidies of our species15.    
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Figure Legends 
Figure 1.  Proteolysis of securin is required for homologue disjunction. a, Western 
blot showing presence of securin in MI oocytes (GVBD+4.5 h; n=100 oocytes).  b, 
Timelapse fluorescence measurement showing securin::GFP expression in a 
representative oocyte (n=22/26).  Insets show paired brightfield and fluorescence images. 
PB formation (arrow) occurred at the end of the decline phase (n=19/26).  c, Fluorescence 
and brightfield overlay images of a securin::GFP-injected oocyte stained with H33342 
showing DNA in the PB and in the oocyte.  d, Timelapse fluorescence measurement of a 
representative oocyte (n=17) showing that securindm::GFP was stable.  Insets show that 
PB formation was inhibited (n=15/17).  e, DNA stained with H33342 at GVBD+14 h 
shows that homologues maintained a metaphase configuration.  f, Air-dried chromosome 
spread of an oocyte (GVBD+16 h) injected with securindm::GFP, showing intact bivalents 
(7/7 oocytes). g, Immunolabelled spindles of securindm::GFP-injected oocytes 
(GVBD+16 h).  Microtubules are green and chromosomes are blue. Scale bars = 20 µm. 
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